15/10/03
2003 3rd quarter sales up 11%
€ millions 2003 2002 % growth 3rd quarter sales 17.39 15.70 11 France & Overseas territories 8.42 7.31 15 Subsidiaries (1) 6.63 6.28 6 Distributors 2.34 2.11 11 Cumulative sales at end September...
24/09/03
2003 1st Half-Year Group Results:Continuation of improving results
The Board of Directors, meeting on 24 September 2003 under the chairmanship of Albert Saporta, approved Stallergènes Group’s consolidated financial statements for the 1st half-year ending 30 June 2003.
(€ millions) 2003...
25/08/03
Allergy to mites:Agreement between Stallergenes and MERISTEM Therapeutics for recombinant allergens production
MERISTEM Therapeutics (Clermont-Ferrand - France) and Stallergenes (Antony - France) announce the signature of an agreement on the industrial feasibility and the production of two mites major allergens in plant.
This agreement...
15/07/03
1st Half-Year Group Sales Up 20%
(€ millions) 2002 2003 % Growth 2nd quarter 17.20 19.24 12% France * 7.99 9.62 20% Subsidiaries ** 6.77 7.19 6% Distributors *** 2.44 2.43 - 1st Half-Year 35.60 42.55 20% France * 17.18 21.46 25% Subsidiaries **...
10/08/07
Note d'information relative à un programme de rachat d'actions propres qui sera soumis à l'approbation de l'assemblée générale mixte des actionnaires le 18 juin 2003.
Only available in French
Société anonyme au capital de 12.160.000 eurosSiège social : 6, rue Alexis de Tocqueville - 92183 Antony393 709 860 R.C.S. Nanterre
En application des articles L 621-8 du Code Monétaire et Financier,...
12/05/03
BIOMAY and Stallergenes have signed a patent licence agreement
Today, Biomay (Vienna – Austria) and Stallergenes (Antony – France) announce the signature of a patent licence agreement on the gene encoding for the birch pollen major allergen Bet v 1a.
This agreement represents an important...
14/04/03
Continued strong growth in sales, 2003 1st Quarter Group sales up 27%
(€ millions) 2003 Q1 % sales 2002 Q1 % sales % increase France *International - subsidiaries **International - distributors *** 11.848.383.09 50.836.013.2 9.197.221.99 50.039.210.8 29%16%55% Total Group sales 23.31 100.0 18.40...
14/04/03
2003 1st Quarter Group sales up 27%: Continued strong growth in sales
(€ millions) 2003 Q1 % sales 2002 Q1 % sales % increase France * International - subsidiaries ** International - distributors *** 11.84 8.38 3.09 50.8 36.0 13.2 9.19 7.22 1.99 50.0 39.2 10.8 29% 16% 55% Total...
15/03/03
2002 results
Sales: +18%Net income increases twofold: 6.3% of salesNet debt down sharply: -40%
The Board of Directors' meeting of 18 March 2002 chaired by Albert Saporta issued the financial statements for the year 2002.
€...
